Drug-Coated Balloon in Primary Percutaneous Coronary Intervention

Drug-Coated Balloon in Primary Percutaneous Coronary Intervention

According to the latest coronary interventional guidelines, a drug-eluting stent is the recommended reperfusion therapy in primary percutaneous coronary intervention (pPCI). However, deficiencies and defects, such as in-stent restenosis (ISR), incomplete stent apposition, stent thrombosis, reinfarct...

Full description

Bibliographic Details
Main Authors:	Hui Zhao, Runran Miao, Fei Lin, Guoan Zhao
Format:	Article
Language:	English
Published:	Hindawi-Wiley 2023-01-01
Series:	Journal of Interventional Cardiology
Online Access:	http://dx.doi.org/10.1155/2023/5210808

Similar Items

Short Term Outcome of Drug Eluting Balloon for Percutaneous Coronary Intervention
by: Maida Anwar, et al.
Published: (2023-12-01)

Comparison of Drug-Coated Balloons and Drug-Eluting Stents in Primary Percutaneous Coronary Interventions for ST-Segment Elevated Myocardial Infarction: A Systemic Review and Meta-Analysis
by: Hu Su, et al.
Published: (2022-05-01)

Drug-Coated Balloon-Only Percutaneous Coronary Intervention for the Treatment of De Novo Coronary Artery Disease: A Systematic Review
by: Hasan Mohiaddin, et al.
Published: (2018-10-01)

Percutaneous coronary intervention for a healed erosion with excimer laser coronary angioplasty and drug-coated balloon angioplasty: a case report
by: Teruo Sekimoto, et al.
Published: (2023-08-01)

Drug-coated Balloons for Small Coronary Vessel Interventions: A Literature Review
by: Thomas Nestelberger, et al.
Published: (2019-11-01)

Long-Term Clinical Outcomes After Percutaneous Coronary Intervention With Drug-Coated Balloon-Only Strategy in de novo Lesions of Large Coronary Arteries
by: Feng-Wang Hu, et al.
Published: (2022-07-01)

Comparison between drug-coated balloons and drug-eluting stents in very small coronary artery interventions
by: Cheng-Hsuan Tsai, et al.
Published: (2022-06-01)

An Avoidable Complication of Percutaneous Coronary Intervention—Entrapment of Stent and Disconnected Balloon Catheter
by: Tsung-Hsien Lin, et al.
Published: (2006-04-01)

The Efficacy of Drug-Coated Balloon for Acute Coronary Syndrome
by: Hirokazu Naganawa, et al.
Published: (2023-01-01)

Scoring balloon versus drug-eluting balloon in coronary intervention for very small coronary vessels
by: Yasser Gaber Metwally, et al.
Published: (2021-01-01)

Drug-coated balloons versus drug-eluting stents in patients with acute myocardial infarction undergoing percutaneous coronary intervention: an updated meta-analysis with trial sequential analysis
by: Ahmed Abdelaziz, et al.
Published: (2023-12-01)

Causes of delay in door-to-balloon time in south-east Asian patients undergoing primary percutaneous coronary intervention.
by: Wen Jun Sim, et al.
Published: (2017-01-01)

Percutaneous coronary intervention for bifurcation: Jailed semi-inﬂated balloon technique
by: Eser Durmaz, et al.
Published: (2018-07-01)

Impact of Chocolate percutaneous transluminal angioplasty balloon on vessel preparation in drug-coated balloon angioplasty for femoropopliteal lesion
by: Shigemitsu Shirai, et al.
Published: (2022-09-01)

Our experience with drug eluting balloons for coronary interventions
by: G. Sengottuvelu, et al.
Published: (2014-11-01)

Correction: Drug-coated balloons versus drug-eluting stents in patients with acute myocardial infarction undergoing percutaneous coronary intervention: an updated meta-analysis with trial sequential analysis
by: Ahmed Abdelaziz, et al.
Published: (2024-01-01)

Appropriate Surrogate Endpoint in Drug-Coated Balloon Trials for Coronary Artery Diseases
by: Xinyue Lang, et al.
Published: (2022-06-01)

Safety and Efficacy of Drug-Coated Balloons in Patients with Acute Coronary Syndromes and Vulnerable Plaque
by: Yu-Bin Zhang BS, et al.
Published: (2022-10-01)

Cardiovascular outcomes following percutaneous coronary intervention with drug-eluting balloons in chronic kidney disease: a retrospective analysis
by: Michael Jonas, et al.
Published: (2020-10-01)

Role of Drug-coated Balloons in Small-vessel Coronary Artery Disease
by: Michael Megaly, et al.
Published: (2019-01-01)

Utilization of Drug-Coated Balloons for the Treatment of Coronary Lesions in the Elderly Population
by: Gal Sella, et al.
Published: (2022-05-01)

Single‐Antiplatelet Treatment After Coronary Angioplasty With Drug‐Coated Balloon
by: Bernardo Cortese, et al.
Published: (2023-03-01)

Drug-coated balloon catheters. Discussing mortality from the coronary perspective
by: Bruno Scheller
Published: (2020-08-01)

Coronary Artery Aneurysm Formation after Drug-Coated Balloon Treatment
by: Jing Huang, et al.
Published: (2018-01-01)

Design of percutaneous transluminal coronary angioplasty balloon catheters
by: C. Amstutz, et al.
Published: (2023-09-01)

Successful management of distal coronary artery perforation with the modified cut balloon technique during percutaneous coronary intervention
by: Lütfi Öcal, et al.
Published: (2022-01-01)

The factors influencing the efficiency of drug-coated balloons
by: Zheng Cao, et al.
Published: (2022-10-01)

Editorial: Primary percutaneous coronary intervention in octogenarians
by: Ertan Ökmen
Published: (2013-06-01)

Novel application of drug-coated balloons in coronary heart disease: A narrative review
by: Lijin Wang, et al.
Published: (2023-03-01)

Long-term outcomes of drug-coated balloons in patients with diffuse coronary lesions
by: Xinyue Yang, et al.
Published: (2022-09-01)

Current state of knowledge on the use of drug-coated balloon in coronary bifurcation lesions
by: José Ramón López-Mínguez, et al.
Published: (2023-02-01)

Drug-coated balloon in the treatment of coronary bifurcation lesions: A hope or hype?
by: Debabrata Dash, et al.
Published: (2022-11-01)

3-Year outcomes in patients with heavily calcified lesions undergoing percutaneous coronary intervention using cutting balloons
by: Wei Liu, et al.
Published: (2022-04-01)

Culprit vessel revascularization first with primary use of a dedicated transradial guiding catheter to reduce door to balloon time in primary percutaneous coronary intervention
by: Jincheng Guo, et al.
Published: (2022-10-01)

Door-to-balloon time in radial versus femoral approach for primary percutaneous coronary intervention in patients with ST-segment elevation myocardial infarction
by: Osama Tayeh, et al.
Published: (2014-06-01)

CHA2DS2-VASc Score Predict No-Reflow Phenomenon in Primary Percutaneous Coronary Intervention in Primary Percutaneous Coronary Intervention
by: Fardin Mirbolouk, et al.
Published: (2018-03-01)

Efficacy and safety of Tornus catheter in percutaneous coronary intervention of hard or balloon-uncrossable chronic total occlusion
by: Mohsen Mohandes, et al.
Published: (2016-09-01)

Drug-Coated Balloons: Drugs Beyond Paclitaxel?
by: Tobias Haase, et al.
Published: (2022-10-01)

Assessing the Coronary Microcirculation in Patients After Primary Percutaneous Coronary Intervention
by: Andy S. C. Yong, et al.
Published: (2018-08-01)

Primary percutaneous coronary intervention in hyperacute inferior STEMI
by: Juan Guzman Olea, et al.
Published: (2022-02-01)